Table of Contents

1 Global Market Overview

• 1.1 Scope of Statistics
  • 1.1.1 Scope of Products
  • 1.1.2 Scope of Manufacturers
  • 1.1.3 Scope of Application
  • 1.1.5 Scope of Regions/Countries
• 1.2 Global Market Size

2 Regional Market

• 2.1 Regional Production
• 2.2 Regional Demand
• 2.3 Regional Trade

3 Key Manufacturers

• 3.1 Bristol-Myers Squibb
  • 3.1.2 Company Information
  • 3.1.2 Product Specifications
  • 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.2 GlaxoSmithKline
  • 3.2.1 Company Information
  • 3.2.2 Product Specifications
  • 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.3 Menarini
  • 3.3.1 Company Information
  • 3.3.2 Product Specifications
  • 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.4 Sanofi
  • 3.4.1 Company Information
  • 3.4.2 Product Specifications
  • 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.5 Ziopharm Oncology
  • 3.5.1 Company Information
  • 3.5.2 Product Specifications
  • 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.6 Alchemia
  • 3.6.1 Company Information
  • 3.6.2 Product Specifications
  • 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.7 Alchemia
  • 3.7.1 Company Information
  • 3.7.2 Product Specifications
  • 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.8 Apotex
  • 3.8.1 Company Information
  • 3.8.2 Product Specifications
  • 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.9 BioMarin Pharmaceutical
  • 3.9.1 Company Information
  • 3.9.2 Product Specifications
  • 3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.10 CellAct Pharma
  • 3.10.1 Company Information
  • 3.10.2 Product Specifications
  • 3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.11 Cerulean Pharma
• 3.12 Cipla
• 3.13 Cornerstone Pharmaceuticals
• 3.14 Curis
• 3.15 CytRx
• 3.16 Eli Lilly
• 3.17 Exelixis
• 3.18 Fresenius Kabi
• 3.19 Genentech
• 3.20 Hikma Pharmaceuticals
• 3.21 Hospira
• 3.22 Intas Pharmaceuticals
• 3.23 Karyopharm Therapeutics
• 3.24 Kyowa Hakko Kirin
• 3.25 Ligand Pharmaceuticals

4 Major Application

• 4.1 Hospital
  • 4.1.1 Overview
  • 4.1.2 Hospital Market Size and Forecast
• 4.2 Clinic
  • 4.2.1 Overview
  • 4.2.2 Clinic Market Size and Forecast
• 4.3 Others
  • 4.3.1 Overview
  • 4.3.2 Others Market Size and Forecast

5 Market by Type

• 5.1 Radiofrequency Ablation (RFA)
  • 5.1.1 Overview
  • 5.1.2 Radiofrequency Ablation (RFA) Market Size and Forecast
• 5.2 Radiation Therapy
  • 5.2.1 Overview
  • 5.2.2 Radiation Therapy Market Size and Forecast
• 5.3 Chemotherapy
  • 5.3.1 Overview
  • 5.3.2 Chemotherapy Market Size and Forecast
• 5.4 Targeted Therapies
  • 5.4.1 Overview
  • 5.4.2 Targeted Therapies Market Size and Forecast
• 5.5 Immunotherapy
  • 5.5.1 Overview
  • 5.5.2 Immunotherapy Market Size and Forecast
• 5.6 Immunotherapy
  • 5.6.1 Overview
  • 5.6.2 Immunotherapy Market Size and Forecast

6 Conclusion

Summary
The global Drugs for Non-small Cell Lung Cancer market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Bristol-Myers Squibb 
GlaxoSmithKline 
Menarini 
Sanofi 
Ziopharm Oncology 
Alchemia 
Alchemia 
Apotex 
BioMarin Pharmaceutical 
CellAct Pharma 
Cerulean Pharma 
Cipla 
Cornerstone Pharmaceuticals 
Curis 
CytRx 
Eli Lilly 
Exelixis 
Fresenius Kabi 
Genentech 
Hikma Pharmaceuticals 
Hospira 
Intas Pharmaceuticals 
Karyopharm Therapeutics 
Kyowa Hakko Kirin 
Ligand Pharmaceuticals
Major applications as follows:
Hospital 
Clinic 
Others
Major Type as follows:
Radiofrequency Ablation (RFA) 
Radiation Therapy 
Chemotherapy 
Targeted Therapies 
Immunotherapy
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa